Aggregated China Business Blogs



Genesis Pharmaceuticals Announces China SFDA Approval For Radix Isatidis Dispersible Tablets

Aggregated Source: China Sourcing News
July 23, 2008|

Genesis Pharmaceuticals Enterprises, Inc., a pharmaceutical company in the People's Republic of China, has announced that the company has received approval from the Chinese State Food and Drug Administration to start producing and distributing Radix Isatidis Dispersible Tablets. Radix Isatidis is an herbal-based traditional Chinese medicine used to cure viral influenza. Radix Isatidis is very popular [...]

Original URL: Click here to visit original article
Copyright China Sourcing News
Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • Tianyin Wins First SFDA Approval
  • AIDA Pharmaceuticals Announces Favorable Clinical Trial Findings
  • China Biologic Receives SFDA Approval For Clinical Trials Of FVIII
  • China Biologic Receives SFDA Approval For Clinical Trials Of FVIII
  • Tongjitang's Osteoperosis Drug Likely to Win FDA Approval

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |